4.8 Article

Mitogenic and progenitor gene programmes in single pilocytic astrocytoma cells

Journal

NATURE COMMUNICATIONS
Volume 10, Issue -, Pages -

Publisher

NATURE PUBLISHING GROUP
DOI: 10.1038/s41467-019-11493-2

Keywords

-

Funding

  1. Pediatric Low-Grade Astrocytoma Fund at the Pediatric Brain Tumor Foundation
  2. Stop and Shop Pediatric Brain Tumor Program
  3. Conquer Cancer Foundation
  4. Strike 3 Foundation ASCOYoung Investigator Award
  5. Michael Mosier Defeat DIPG
  6. ChadTough Foundation Fellowship
  7. NIH [PO1CA142536, K99CA201592, R01CA188228, R01CA142536, R01CA219943, F32CA180653, 2U19AI089992, 1U54CA217377, 2P01AI039671, 5U24AI118672, 2RM1HG006193, 1R33CA202820, 2R01HL095791, 1R01AI138546, 1R01HL134539, 1R01DA046277]
  8. St Baldrick's Foundation
  9. Friends of DFCI
  10. Team Jack Foundation
  11. Andrysiak Fund for LGG
  12. Jared Branfman Sunflowers For Life Fund For Pediatric Brain And Spinal Cancer Research
  13. Gray Matters Brain Cancer Foundation
  14. Ian's Friends Foundation
  15. Sontag Foundation
  16. Searle Scholars Program
  17. Beckman Young Investigator Program
  18. Pew-tewart Scholars
  19. Sloan Fellowship in Chemistry
  20. Bill and Melinda Gates Foundation [OPP1139972, OPP1137006, OPP1116944]
  21. Bill and Melinda Gates Foundation [OPP1139972, OPP1116944, OPP1137006] Funding Source: Bill and Melinda Gates Foundation

Ask authors/readers for more resources

Pilocytic astrocytoma (PA), the most common childhood brain tumor, is a low-grade glioma with a single driver BRAF rearrangement. Here, we perform scRNAseq in six PAs using methods that enabled detection of the rearrangement. When compared to higher-grade gliomas, a strikingly higher proportion of the PA cancer cells exhibit a differentiated, astrocyte-like phenotype. A smaller proportion of cells exhibit a progenitor-like phenotype with evidence of proliferation. These express a mitogen-activated protein kinase (MAPK) programme that was absent from higher-grade gliomas. Immune cells, especially microglia, comprise 40% of all cells in the PAs and account for differences in bulk expression profiles between tumor locations and subtypes. These data indicate that MAPK signaling is restricted to relatively undifferentiated cancer cells in PA, with implications for investigational therapies directed at this pathway.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available